Testing effectiveness (Phase 2)Active Not RecruitingNCT07187375
What this trial is testing
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
Who this might be right for
Congenital Adrenal Hyperplasia
Neurocrine Switzerland GmbH 7